Multidisciplinary Cardiovascular Annals

Published by: Neoscriber Demo Publisher
Crossmark

Danon Disease: A Challenging Case with Diagnosis of Hypertrophic Cardiomyopathy

Ahmad Amin 1 , Meysam Khoshavi 1 , * , Sepideh Taghavi 1 , Nasim Naderi 1 , Nejat Mahdieh 2 , Zahra Emkanjoo 1 and Mitra Chitsazan 3
Authors Information
1 Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
2 Cardiogenetic Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
3 Cardiovascular Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
Article information
  • Multidisciplinary Cardiovascular Annals: January 31, 2019, 10 (1); e87232
  • Published Online: May 12, 2019
  • Article Type: Case Report
  • Received: December 9, 2018
  • Revised: April 12, 2019
  • Accepted: April 16, 2019
  • DOI: 10.5812/mca.87232

To Cite: Amin A, Khoshavi M, Taghavi S, Naderi N, Mahdieh N , et al. Danon Disease: A Challenging Case with Diagnosis of Hypertrophic Cardiomyopathy, Multidiscip Cardio Annal. 2019 ; 10(1):e87232. doi: 10.5812/mca.87232.

Abstract
Copyright © 2019, Multidisciplinary Cardiovascular Annals. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
Footnotes
References
  • 1. D'Souza R S, Levandowski C, Slavov D, Graw SL, Allen LA, Adler E, et al. Danon disease: Clinical features, evaluation, and management. Circ Heart Fail. 2014;7(5):843-9. doi: 10.1161/CIRCHEARTFAILURE.114.001105. [PubMed: 25228319]. [PubMed Central: PMC4169002].
  • 2. Kim J, Parikh P, Mahboob M, Arrighi JA, Atalay MK, Rowin EJ, et al. Asymptomatic young man with Danon disease. Tex Heart Inst J. 2014;41(3):332-4. doi: 10.14503/THIJ-13-3279. [PubMed: 24955057]. [PubMed Central: PMC4060354].
  • 3. Charron P, Villard E, Sebillon P, Laforet P, Maisonobe T, Duboscq-Bidot L, et al. Danon's disease as a cause of hypertrophic cardiomyopathy: A systematic survey. Heart. 2004;90(8):842-6. doi: 10.1136/hrt.2003.029504. [PubMed: 15253947]. [PubMed Central: PMC1768382].
  • 4. Arad M, Maron BJ, Gorham JM, Johnson WH Jr, Saul JP, Perez-Atayde AR, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med. 2005;352(4):362-72. doi: 10.1056/NEJMoa033349. [PubMed: 15673802].
  • 5. Fanin M, Nascimbeni AC, Fulizio L, Spinazzi M, Melacini P, Angelini C. Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease. Am J Pathol. 2006;168(4):1309-20. doi: 10.2353/ajpath.2006.050646. [PubMed: 16565504]. [PubMed Central: PMC1606547].
  • 6. Sugie K, Koori T, Yamamoto A, Ogawa M, Hirano M, Inoue K, et al. Characterization of Danon disease in a male patient and his affected mother. Neuromuscul Disord. 2003;13(9):708-11. [PubMed: 14561493].
  • 7. Yang Z, Vatta M. Danon disease as a cause of autophagic vacuolar myopathy. Congenit Heart Dis. 2007;2(6):404-9. doi: 10.1111/j.1747-0803.2007.00132.x. [PubMed: 18377432].
  • 8. Bertini E, Donati MA, Broda P, Cassandrini D, Petrini S, Dionisi-Vici C, et al. Phenotypic heterogeneity in two unrelated Danon patients associated with the same LAMP-2 gene mutation. Neuropediatrics. 2005;36(5):309-13. doi: 10.1055/s-2005-872844. [PubMed: 16217705].
  • 9. Rowland TJ, Sweet ME, Mestroni L, Taylor MR. Danon disease - dysregulation of autophagy in a multisystem disorder with cardiomyopathy. J Cell Sci. 2016;129(11):2135-43. doi: 10.1242/jcs.184770. [PubMed: 27165304]. [PubMed Central: PMC4920246].
  • 10. Boucek D, Jirikowic J, Taylor M. Natural history of Danon disease. Genet Med. 2011;13(6):563-8. doi: 10.1097/GIM.0b013e31820ad795. [PubMed: 21415759].
  • 11. Sugie K, Yamamoto A, Murayama K, Oh SJ, Takahashi M, Mora M, et al. Clinicopathological features of genetically confirmed Danon disease. Neurology. 2002;58(12):1773-8. [PubMed: 12084876].
  • 12. Maron BJ, Roberts WC, Arad M, Haas TS, Spirito P, Wright GB, et al. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA. 2009;301(12):1253-9. doi: 10.1001/jama.2009.371. [PubMed: 19318653]. [PubMed Central: PMC4106257].
  • 13. Van Der Starre P, Deuse T, Pritts C, Brun C, Vogel H, Oyer P. Late profound muscle weakness following heart transplantation due to Danon disease. Muscle Nerve. 2013;47(1):135-7. doi: 10.1002/mus.23517. [PubMed: 23168931].
  • 14. Cheng Z, Fang Q. Danon disease: focusing on heart. J Hum Genet. 2012;57(7):407-10. doi: 10.1038/jhg.2012.72. [PubMed: 22695892].
  • 15. D'Souza R S, Mestroni L, Taylor MRG. Danon disease for the cardiologist: Case report and review of the literature. J Community Hosp Intern Med Perspect. 2017;7(2):107-14. doi: 10.1080/20009666.2017.1324239. [PubMed: 28638575]. [PubMed Central: PMC5473185].
  • 16. Konrad T, Sonnenschein S, Schmidt FP, Mollnau H, Bock K, Ocete BQ, et al. Cardiac arrhythmias in patients with Danon disease. Europace. 2017;19(7):1204-10. doi: 10.1093/europace/euw215. [PubMed: 27742774].
  • 17. Ruiz-Guerrero L, Barriales-Villa R. Storage diseases with hypertrophic cardiomyopathy phenotype. Glob Cardiol Sci Pract. 2018;2018(3):28. doi: 10.21542/gcsp.2018.28. [PubMed: 30393640]. [PubMed Central: PMC6209457].
  • 18. Nishino I. Autophagic vacuolar myopathy. Semin Pediatr Neurol. 2006;13(2):90-5. doi: 10.1016/j.spen.2006.06.004. [PubMed: 17027858].
  • 19. Yardeni M, Weisman O, Mandel H, Weinberger R, Quarta G, Salazar-Mendiguchia J, et al. Psychiatric and cognitive characteristics of individuals with Danon disease (LAMP2 gene mutation). Am J Med Genet A. 2017;173(9):2461-6. doi: 10.1002/ajmg.a.38320. [PubMed: 28627787]. [PubMed Central: PMC5561494].
  • 20. Dickens C, Cherrington A, McGowan L. Depression and health-related quality of life in people with coronary heart disease: A systematic review. Eur J Cardiovasc Nurs. 2012;11(3):265-75. doi: 10.1177/1474515111430928. [PubMed: 22457381].
  • 21. Wang L, Wang J, Cai W, Shi Y, Zhou X, Guo G, et al. A critical evaluation of liver pathology in humans with Danon disease and experimental correlates in a rat model of LAMP-2 deficiency. Clin Rev Allergy Immunol. 2017;53(1):105-16. doi: 10.1007/s12016-017-8598-3. [PubMed: 28124283].
  • 22. Thompson DA, Constable PA, Liasis A, Walters B, Esteban MT. The physiology of the retinal pigment epithelium in Danon disease. Retina. 2016;36(3):629-38. doi: 10.1097/IAE.0000000000000736. [PubMed: 26398689].
  • 23. Linhart A, Cecchi F. Common presentation of rare diseases: Left ventricular hypertrophy and diastolic dysfunction. Int J Cardiol. 2018;257:344-50. doi: 10.1016/j.ijcard.2018.01.006. [PubMed: 29506729].
  • 24. Nucifora G, Miani D, Piccoli G, Proclemer A. Cardiac magnetic resonance imaging in Danon disease. Cardiology. 2012;121(1):27-30. doi: 10.1159/000336448. [PubMed: 22378182].
  • 25. Vago H, Somloi M, Toth A, Merkely B. Danon disease: a rare cause of left ventricular hypertrophy with cardiac magnetic resonance follow-up. Eur Heart J. 2016;37(21):1703. doi: 10.1093/eurheartj/ehv332. [PubMed: 26206213].
  • 26. Lines MA, Hewson S, Halliday W, Sabatini PJ, Stockley T, Dipchand AI, et al. Danon disease due to a novel LAMP2 microduplication. JIMD Rep. 2014;14:11-6. doi: 10.1007/8904_2013_277. [PubMed: 24222494]. [PubMed Central: PMC4213339].
  • 27. Taylor MR, Ku L, Slavov D, Cavanaugh J, Boucek M, Zhu X, et al. Danon disease presenting with dilated cardiomyopathy and a complex phenotype. J Hum Genet. 2007;52(10):830-5. doi: 10.1007/s10038-007-0184-8. [PubMed: 17899313].
  • 28. Sugie K, Noguchi S, Kozuka Y, Arikawa-Hirasawa E, Tanaka M, Yan C, et al. Autophagic vacuoles with sarcolemmal features delineate Danon disease and related myopathies. J Neuropathol Exp Neurol. 2005;64(6):513-22. [PubMed: 15977643].
  • 29. Nascimbeni AC, Fanin M, Angelini C, Sandri M. Autophagy dysregulation in Danon disease. Cell Death Dis. 2017;8(1). e2565. doi: 10.1038/cddis.2016.475. [PubMed: 28102838]. [PubMed Central: PMC5386379].
  • 30. Guo LY, Wang B, Shen M, Liu B, Liu LW. Cardiac resynchronization therapy-pacemaker implantation guided by three-dimensional electroanatomic mapping for a Chinese young man with Danon disease. Chin Med J (Engl). 2018;131(22):2760-2. doi: 10.4103/0366-6999.245156. [PubMed: 30425207]. [PubMed Central: PMC6247605].
  • 31. Zaki A, Zaidi A, Newman WG, Garratt CJ. Advantages of a subcutaneous implantable cardioverter-defibrillator in LAMP2 hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2013;24(9):1051-3. doi: 10.1111/jce.12142. [PubMed: 23577876].
  • 32. Poignant S, Bourguignon T, Espitalier F. Heart transplantation in Danon disease: A single family displaying diverse phenotypes. J Heart Lung Transplant. 2017. doi: 10.1016/j.healun.2017.10.027. [PubMed: 29153639].
  • 33. Samad F, Jain R, Jan MF, Sulemanjee NZ, Menaria P, Kalvin L, et al. Malignant cardiac phenotypic expression of Danon disease (LAMP2 cardiomyopathy). Int J Cardiol. 2017;245:201-6. doi: 10.1016/j.ijcard.2017.06.031. [PubMed: 28874292].
  • 34. Sankaranarayanan R, Fleming EJ, Garratt CJ. Mimics of hypertrophic cardiomyopathy - diagnostic clues to aid early identification of phenocopies. Arrhythm Electrophysiol Rev. 2013;2(1):36-40. doi: 10.15420/aer.2013.2.1.36. [PubMed: 26835038]. [PubMed Central: PMC4711498].
  • 35. Arad M. Cardiac Danon disease: Insights and challenges. Int J Cardiol. 2017;245:211-2. doi: 10.1016/j.ijcard.2017.07.106. [PubMed: 28874294].
  • 36. Flotte TR, Daniels E, Benson J, Bevett-Rose JM, Cornetta K, Diggins M, et al. The gene therapy resource program: A decade of dedication to translational research by the national heart, lung, and blood institute. Hum Gene Ther Clin Dev. 2017;28(4):178-86. doi: 10.1089/humc.2017.170. [PubMed: 29130351]. [PubMed Central: PMC5733658].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments